Shorts Set $1.00 Price Target on Inovio (INO) $9.20.
Interesting battle brewing!
LIVE CHART
Inovio shares tumble 8% after short seller Muddy Waters says don't believe the COVID-19 vaccine hype (MarketWatch).
Inovio Pharmaceuticals Inc. shares INO, -6.19% slid...
Deficiency of Glutathione as the Most Likely Cause of Serious Manifestations and Death in...
American Chemical Society
May 2020.
Higher rates of serious illness and death from coronavirus SARS-CoV-2 (COVID-19) infection among older people and those who have comorbidities...
‘Amazing potential.’ UM doctor to start stem cell trial for coronavirus patients (Miami Herald)
BY BEN CONARCK APRIL 16, 2020
A team of doctors at the University of Miami won emergency federal approval to use stem cell therapy on...
Dalrada (DFCO) Legal Counsel
CONTINUOUSLY UPDATED
Dalrada Financial Adds Robbe to Board of DirectorsDalrada Financial Corporation Hires Fletcher Robbe International
Dalrada Financial Adds Robbe to Board of Directors
HENDERSON, Nev., Aug....
Latest article
Cabaletta (CABA) Surges 44% on Massive Volume Spike.
Biotech 12 Pack Off to Nice Start..
Cabaletta up 35%, GeoVax up 75%, and Replimune up 62%. All since late April!
Biotech Stock Review is...
GeoVax (GOVX) Surges 51% on Massive Volume Spike.
MonkeyPox and Gedeptin Related News Spark New Investor Interest.
MARKET BRIEF
On a quiet Wednesday afternoon, the 29th, while we were nearing completion of an updated...
Paving Past Obstacles on the Path to US Biosecurity
GeoVax’s CEO calls on government support to bolster domestic biotechnology and keep pace with China.
National biosecurity has become a frequent topic of conversation in...
